T HE development of new roentgen contrast agents has made individual angiographic procedures safer. However, this advance must be weighed against the eontinually widening use of diagnostic angiology and the increasing demand for greater roentgen contrast in these studies. It is our considered opinion that there is probably no known contrast agent that is not capable of producing a necrotizing lesion if it reaches the vascular bed of an organ in the mainstream of its flow in a concentration approaching the high initial level required for angiography. Because of this element of danger inherent in modern diagnostic angiology the prompt reporting of experimental studies demonstrating a dramatic protective effect against contrast medium injury to the central nervous system is warranted, despite the fact that a complete understanding of the mechanism of the protective action has not yet been attained.
EXPERIMENTAL
The methodology, including the site of test, the toxic roentgen contrast agent, the criteria of injury, and the quantitative grading system has been previously described. 4 In brief, the rapid injection of a 1 ce. per kg. dose of 70 per cent Na acetrizoate (Urokon) into the aorta via a retrograde femoral artery catheter will produce a predictable toxic reaction. This injury is characterized by a severe tonie-clonic spinal convulsion, a permanent paralysis of the hind limbs, and a massive necrosis of the lumbosacral cord.
The theoretieal approaches explored and the various agents and procedures used in seeking a protective mechanism against contrast medium injury are outlined below: In these studies all agents were administered through the catheter in the femoral artery prior to the injection of Urokon. The volume and rate of injection were adjusted so that the primary circulation of these agents was through the vascular bed to be exposed later to Urokon. In Table 1 the therapeutic agents tested, including dosage, concentration, and time of 
